Clinical Hurdles of Pluripotent Stem Cell Therapy
January 12, 2017 - Stanford Medicine Scope
Bio-X affiliate Ravindra Majeti and then postdoctoral fellow Mark Chao became the first to reset a human...
December 22, 2016 - Stanford Medicine Scope
New research from Bio-X affiliates Marlene Rabinovitch, Michael Snyder, and Joseph Wu provides a great...
October 13, 2016 - Stanford Medicine News Center
From Bio-X affiliates Holden Maecker, Joseph Wu, Mark Davis, and Francois Haddad, an assessment...